Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Fusogenic-Reactor-Based Lateral Flow Assay for Extraction-free, Multiplexed Viral RNA Detection

Project description

Multiplex home test for virus detection

Multiplex assays that can simultaneously detect a number of viruses such as influenza A and SARS-CoV-2 are essential for effective disease surveillance. Existing viral diagnostics for home use lack accuracy while PCR-based tests are laborious and require specialised resources. With the support of the Marie Skłodowska-Curie Actions programme, the FusoLipo-LFA project will develop an innovative test based on lipid vesicles that mimic cells and can fuse with viruses. These vesicles contain special molecular tools that can detect viral RNA and amplify the signal, facilitating the detection of just a few viral particles. This approach overcomes complex extraction steps and offers fast, accurate and user-friendly home testing for multiple viruses.

Objective

In this fellowship, I will leverage recent advances in membrane-fusion-based biosensor technologies to develop an extraction-free, multiplexed lateral flow assay (LFA) for rapid, home-based viral RNA detection. The COVID-19 pandemic exposed critical limitations in virus diagnostics, with antigen-based kits lacking sensitivity and specificity, while RT-qPCR tests, though accurate, are slow, resource-intensive, and impractical for widespread deployment—highlighting the urgent need for field-deployable molecular assays that deliver reliable results. Given the coexistence of multiple respiratory viruses, multiplexed detection is also crucial. This project aims to combine my expertise in membrane-fusion-based biosensor design with Professor Dame Molly Stevens' (University of Oxford) expertise in LFA-based biosensors to create a multiplex LFA system for viral RNA detection using membrane fusion approach. The system will first employ cell-mimetic fusogenic lipid vesicles (FusoLipo) encapsulating CRISPR toolkits, facilitating viral membrane fusion, RNA capture, and CRISPR-mediated detection. By utilizing two types of FusoLipo, the platform can simultaneously detect influenza A (H1N1) and SARS-CoV-2 without the need for complex RNA extraction, minimizing contamination risks. Once the vesicle’s cargo is applied to the LFA, catalytic nanoparticles (Nanozyme) will amplify the signal at the detection bands, increasing sensitivity. This platform ultimately provides a accurate, and user-friendly solution for home-based multiplexed viral RNA detection. Through this fellowship, I will gain access to specialized expertise and cutting-edge facilities in lipid vesicle formulation, molecular technology, LFA development, and inorganic materials synthesis in the Stevens group, alongside advanced instrumentation to characterize vesicles at the single-particle level and further study virus-FusoLipo membrane fusion, significantly advancing my capabilities in diagnostic biosensor innovation.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Net EU contribution
€ 260 347,92
Address
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
United Kingdom
Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data